HONG KONG – Early oral administration of an immune modulator that is normally used for treatment of relapsing multiple sclerosis (MS) significantly reduced brain inflammation and improved the clinical ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The research, published in ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system characterized by periods of relapse and remission of neurological symptoms and progression of disability over time. Although ...

Multiple sclerosis attacks the protective coating around the nervous system. People with the condition often experience periods of severe symptoms, or flares. The flares may become more frequent over ...

Multiple sclerosis (MS) is an autoimmune disease. The defense system that usually protects patients from external aggression turns on its own cells and attacks them for reasons that are not yet known.

PPMS is a less common form of MS characterized by a gradual worsening of symptoms from the onset, whereas RRMS involves distinct relapses followed by periods of remission. PPMS is typically diagnosed ...